Exact Mass: 428.2675

Exact Mass Matches: 428.2675

Found 144 metabolites which its exact mass value is equals to given mass value 428.2675, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

4,4-Diapolycopenedial

(all-E)-2,6,10,15,19,23-hexamethyltetracosa-2,4,6,8,10,12,14,16,18,20,22-undecaenedial

C30H36O2 (428.2715)


   

Nonaethylene glycol monomethyl ether

Nonaethylene glycol monomethyl ether

C19H40O10 (428.2621)


   

MG(PGF2alpha/0:0/0:0)

(2S)-2,3-Dihydroxypropyl (5E)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]hept-5-enoic acid

C23H40O7 (428.2774)


MG(PGF2alpha/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

   

MG(PGE1/0:0/0:0)

(2S)-2,3-Dihydroxypropyl 7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]heptanoic acid

C23H40O7 (428.2774)


MG(PGE1/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

   

MG(PGD1/0:0/0:0)

(2S)-2,3-Dihydroxypropyl 7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]heptanoic acid

C23H40O7 (428.2774)


MG(PGD1/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

   

MG(0:0/PGF2alpha/0:0)

1,3-dihydroxypropan-2-yl (5E)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]hept-5-enoate

C23H40O7 (428.2774)


MG(0:0/PGF2alpha/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

   

MG(0:0/PGE1/0:0)

1,3-Dihydroxypropan-2-yl 7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]heptanoic acid

C23H40O7 (428.2774)


MG(0:0/PGE1/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

   

MG(0:0/PGD1/0:0)

1,3-Dihydroxypropan-2-yl 7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]heptanoic acid

C23H40O7 (428.2774)


MG(0:0/PGD1/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

   
   

Prostaglandin F2alpha-1-glyceryl ester

Prostaglandin F2alpha-1-glyceryl ester

C23H40O7 (428.2774)


   

Gly Lys Lys Pro

(2S)-1-[(2S)-6-amino-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]hexanoyl]pyrrolidine-2-carboxylic acid

C19H36N6O5 (428.2747)


   

Gly Lys Pro Lys

(2S)-6-amino-2-{[(2S)-1-[(2S)-6-amino-2-(2-aminoacetamido)hexanoyl]pyrrolidin-2-yl]formamido}hexanoic acid

C19H36N6O5 (428.2747)


   

Gly Pro Lys Lys

(2S)-6-amino-2-[(2S)-6-amino-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}hexanamido]hexanoic acid

C19H36N6O5 (428.2747)


   

Ile Ile Pro Ser

(2S)-2-{[(2S)-1-[(2S,3S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanoic acid

C20H36N4O6 (428.2635)


   

Ile Ile Ser Pro

(2S)-1-[(2S)-2-[(2S,3S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylpentanamido]-3-hydroxypropanoyl]pyrrolidine-2-carboxylic acid

C20H36N4O6 (428.2635)


   

Ile Leu Pro Ser

(2S)-2-{[(2S)-1-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanoic acid

C20H36N4O6 (428.2635)


   

Ile Leu Ser Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-methylpentanamido]-3-hydroxypropanoyl]pyrrolidine-2-carboxylic acid

C20H36N4O6 (428.2635)


   

Ile Pro Ile Ser

(2S)-2-[(2S,3S)-2-{[(2S)-1-[(2S,3S)-2-amino-3-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanamido]-3-hydroxypropanoic acid

C20H36N4O6 (428.2635)


   

Ile Pro Leu Ser

(2S)-2-[(2S)-2-{[(2S)-1-[(2S,3S)-2-amino-3-methylpentanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanamido]-3-hydroxypropanoic acid

C20H36N4O6 (428.2635)


   

Ile Pro Ser Ile

(2S,3S)-2-[(2S)-2-{[(2S)-1-[(2S,3S)-2-amino-3-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanamido]-3-methylpentanoic acid

C20H36N4O6 (428.2635)


   

Ile Pro Ser Leu

(2S)-2-[(2S)-2-{[(2S)-1-[(2S,3S)-2-amino-3-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanamido]-4-methylpentanoic acid

C20H36N4O6 (428.2635)


   

Ile Pro Thr Val

(2S)-2-[(2S,3R)-2-{[(2S)-1-[(2S,3S)-2-amino-3-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanamido]-3-methylbutanoic acid

C20H36N4O6 (428.2635)


   

Ile Pro Val Thr

(2S,3R)-2-[(2S)-2-{[(2S)-1-[(2S,3S)-2-amino-3-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanamido]-3-hydroxybutanoic acid

C20H36N4O6 (428.2635)


   

Ile Ser Ile Pro

(2S)-1-[(2S,3S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-hydroxypropanamido]-3-methylpentanoyl]pyrrolidine-2-carboxylic acid

C20H36N4O6 (428.2635)


   

Ile Ser Leu Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-hydroxypropanamido]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C20H36N4O6 (428.2635)


   

Ile Ser Pro Ile

(2S,3S)-2-{[(2S)-1-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanoic acid

C20H36N4O6 (428.2635)


   

Ile Ser Pro Leu

(2S)-2-{[(2S)-1-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanoic acid

C20H36N4O6 (428.2635)


   

Ile Thr Pro Val

(2S)-2-{[(2S)-1-[(2S,3R)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C20H36N4O6 (428.2635)


   

Ile Thr Val Pro

(2S)-1-[(2S)-2-[(2S,3R)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-hydroxybutanamido]-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C20H36N4O6 (428.2635)


   

Ile Val Pro Thr

(2S,3R)-2-{[(2S)-1-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanoic acid

C20H36N4O6 (428.2635)


   

Ile Val Thr Pro

(2S)-1-[(2S,3R)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylbutanamido]-3-hydroxybutanoyl]pyrrolidine-2-carboxylic acid

C20H36N4O6 (428.2635)


   

Lys Gly Lys Pro

(2S)-1-[(2S)-6-amino-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}hexanoyl]pyrrolidine-2-carboxylic acid

C19H36N6O5 (428.2747)


   

Lys Gly Pro Lys

(2S)-6-amino-2-{[(2S)-1-{2-[(2S)-2,6-diaminohexanamido]acetyl}pyrrolidin-2-yl]formamido}hexanoic acid

C19H36N6O5 (428.2747)


   

Lys Lys Gly Pro

(2S)-1-{2-[(2S)-6-amino-2-[(2S)-2,6-diaminohexanamido]hexanamido]acetyl}pyrrolidine-2-carboxylic acid

C19H36N6O5 (428.2747)


   

Lys Lys Pro Gly

2-{[(2S)-1-[(2S)-6-amino-2-[(2S)-2,6-diaminohexanamido]hexanoyl]pyrrolidin-2-yl]formamido}acetic acid

C19H36N6O5 (428.2747)


   

Lys Pro Gly Lys

(2S)-6-amino-2-(2-{[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidin-2-yl]formamido}acetamido)hexanoic acid

C19H36N6O5 (428.2747)


   

Lys Pro Lys Gly

2-[(2S)-6-amino-2-{[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidin-2-yl]formamido}hexanamido]acetic acid

C19H36N6O5 (428.2747)


   

Leu Ile Pro Ser

(2S)-2-{[(2S)-1-[(2S,3S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanoic acid

C20H36N4O6 (428.2635)


   

Leu Ile Ser Pro

(2S)-1-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylpentanamido]-3-hydroxypropanoyl]pyrrolidine-2-carboxylic acid

C20H36N4O6 (428.2635)


   

Leu Leu Pro Ser

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanoic acid

C20H36N4O6 (428.2635)


   

Leu Leu Ser Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-methylpentanamido]-3-hydroxypropanoyl]pyrrolidine-2-carboxylic acid

C20H36N4O6 (428.2635)


   

Leu Pro Ile Ser

(2S)-2-[(2S,3S)-2-{[(2S)-1-[(2S)-2-amino-4-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanamido]-3-hydroxypropanoic acid

C20H36N4O6 (428.2635)


   

Leu Pro Leu Ser

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-methylpentanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanamido]-3-hydroxypropanoic acid

C20H36N4O6 (428.2635)


   

Leu Pro Ser Ile

(2S,3S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanamido]-3-methylpentanoic acid

C20H36N4O6 (428.2635)


   

Leu Pro Ser Leu

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanamido]-4-methylpentanoic acid

C20H36N4O6 (428.2635)


   

Leu Pro Thr Val

(2S)-2-[(2S,3R)-2-{[(2S)-1-[(2S)-2-amino-4-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanamido]-3-methylbutanoic acid

C20H36N4O6 (428.2635)


   

Leu Pro Val Thr

(2S,3R)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanamido]-3-hydroxybutanoic acid

C20H36N4O6 (428.2635)


   

Leu Ser Ile Pro

(2S)-1-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-hydroxypropanamido]-3-methylpentanoyl]pyrrolidine-2-carboxylic acid

C20H36N4O6 (428.2635)


   

Leu Ser Leu Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-hydroxypropanamido]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C20H36N4O6 (428.2635)


   

Leu Ser Pro Ile

(2S,3S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanoic acid

C20H36N4O6 (428.2635)


   

Leu Ser Pro Leu

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanoic acid

C20H36N4O6 (428.2635)


   

Leu Thr Pro Val

(2S)-2-{[(2S)-1-[(2S,3R)-2-[(2S)-2-amino-4-methylpentanamido]-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C20H36N4O6 (428.2635)


   

Leu Thr Val Pro

(2S)-1-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-4-methylpentanamido]-3-hydroxybutanamido]-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C20H36N4O6 (428.2635)


   

Leu Val Pro Thr

(2S,3R)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanoic acid

C20H36N4O6 (428.2635)


   

Leu Val Thr Pro

(2S)-1-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylbutanamido]-3-hydroxybutanoyl]pyrrolidine-2-carboxylic acid

C20H36N4O6 (428.2635)


   

Pro Gly Lys Lys

(2S)-6-amino-2-[(2S)-6-amino-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}hexanamido]hexanoic acid

C19H36N6O5 (428.2747)


   

Pro Ile Ile Ser

(2S)-3-hydroxy-2-[(2S,3S)-3-methyl-2-[(2S,3S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]pentanamido]propanoic acid

C20H36N4O6 (428.2635)


   

Pro Ile Leu Ser

(2S)-3-hydroxy-2-[(2S)-4-methyl-2-[(2S,3S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]pentanamido]propanoic acid

C20H36N4O6 (428.2635)


   

Pro Ile Ser Ile

(2S,3S)-2-[(2S)-3-hydroxy-2-[(2S,3S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]propanamido]-3-methylpentanoic acid

C20H36N4O6 (428.2635)


   

Pro Ile Ser Leu

(2S)-2-[(2S)-3-hydroxy-2-[(2S,3S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]propanamido]-4-methylpentanoic acid

C20H36N4O6 (428.2635)


   

Pro Ile Thr Val

(2S)-2-[(2S,3R)-3-hydroxy-2-[(2S,3S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]butanamido]-3-methylbutanoic acid

C20H36N4O6 (428.2635)


   

Pro Ile Val Thr

(2S,3R)-3-hydroxy-2-[(2S)-3-methyl-2-[(2S,3S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]butanamido]butanoic acid

C20H36N4O6 (428.2635)


   

Pro Lys Gly Lys

(2S)-6-amino-2-{2-[(2S)-6-amino-2-[(2S)-pyrrolidin-2-ylformamido]hexanamido]acetamido}hexanoic acid

C19H36N6O5 (428.2747)


   

Pro Lys Lys Gly

2-[(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-pyrrolidin-2-ylformamido]hexanamido]hexanamido]acetic acid

C19H36N6O5 (428.2747)


   

Pro Leu Ile Ser

(2S)-3-hydroxy-2-[(2S,3S)-3-methyl-2-[(2S)-4-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]pentanamido]propanoic acid

C20H36N4O6 (428.2635)


   

Pro Leu Leu Ser

(2S)-3-hydroxy-2-[(2S)-4-methyl-2-[(2S)-4-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]pentanamido]propanoic acid

C20H36N4O6 (428.2635)


   

Pro Leu Ser Ile

(2S,3S)-2-[(2S)-3-hydroxy-2-[(2S)-4-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]propanamido]-3-methylpentanoic acid

C20H36N4O6 (428.2635)


   

Pro Leu Ser Leu

(2S)-2-[(2S)-3-hydroxy-2-[(2S)-4-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]propanamido]-4-methylpentanoic acid

C20H36N4O6 (428.2635)


   

Pro Leu Thr Val

(2S)-2-[(2S,3R)-3-hydroxy-2-[(2S)-4-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]butanamido]-3-methylbutanoic acid

C20H36N4O6 (428.2635)


   

Pro Leu Val Thr

(2S,3R)-3-hydroxy-2-[(2S)-3-methyl-2-[(2S)-4-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]butanamido]butanoic acid

C20H36N4O6 (428.2635)


   

Pro Ser Ile Ile

(2S,3S)-2-[(2S,3S)-2-[(2S)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-methylpentanamido]-3-methylpentanoic acid

C20H36N4O6 (428.2635)


   

Pro Ser Ile Leu

(2S)-2-[(2S,3S)-2-[(2S)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-methylpentanamido]-4-methylpentanoic acid

C20H36N4O6 (428.2635)


   

Pro Ser Leu Ile

(2S,3S)-2-[(2S)-2-[(2S)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-4-methylpentanamido]-3-methylpentanoic acid

C20H36N4O6 (428.2635)


   

Pro Ser Leu Leu

(2S)-2-[(2S)-2-[(2S)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-4-methylpentanamido]-4-methylpentanoic acid

C20H36N4O6 (428.2635)


   

Pro Thr Ile Val

(2S)-2-[(2S,3S)-2-[(2S,3R)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-3-methylpentanamido]-3-methylbutanoic acid

C20H36N4O6 (428.2635)


   

Pro Thr Leu Val

(2S)-2-[(2S)-2-[(2S,3R)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-4-methylpentanamido]-3-methylbutanoic acid

C20H36N4O6 (428.2635)


   

Pro Thr Val Ile

(2S,3S)-2-[(2S)-2-[(2S,3R)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-3-methylbutanamido]-3-methylpentanoic acid

C20H36N4O6 (428.2635)


   

Pro Thr Val Leu

(2S)-2-[(2S)-2-[(2S,3R)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-3-methylbutanamido]-4-methylpentanoic acid

C20H36N4O6 (428.2635)


   

Pro Val Ile Thr

(2S,3R)-3-hydroxy-2-[(2S,3S)-3-methyl-2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]pentanamido]butanoic acid

C20H36N4O6 (428.2635)


   

Pro Val Leu Thr

(2S,3R)-3-hydroxy-2-[(2S)-4-methyl-2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]pentanamido]butanoic acid

C20H36N4O6 (428.2635)


   

Pro Val Thr Ile

(2S,3S)-2-[(2S,3R)-3-hydroxy-2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]butanamido]-3-methylpentanoic acid

C20H36N4O6 (428.2635)


   

Pro Val Thr Leu

(2S)-2-[(2S,3R)-3-hydroxy-2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]butanamido]-4-methylpentanoic acid

C20H36N4O6 (428.2635)


   

Ser Ile Ile Pro

(2S)-1-[(2S,3S)-2-[(2S,3S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-methylpentanamido]-3-methylpentanoyl]pyrrolidine-2-carboxylic acid

C20H36N4O6 (428.2635)


   

Ser Ile Leu Pro

(2S)-1-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-methylpentanamido]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C20H36N4O6 (428.2635)


   

Ser Ile Pro Ile

(2S,3S)-2-{[(2S)-1-[(2S,3S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanoic acid

C20H36N4O6 (428.2635)


   

Ser Ile Pro Leu

(2S)-2-{[(2S)-1-[(2S,3S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-methylpentanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanoic acid

C20H36N4O6 (428.2635)


   

Ser Leu Ile Pro

(2S)-1-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-methylpentanamido]-3-methylpentanoyl]pyrrolidine-2-carboxylic acid

C20H36N4O6 (428.2635)


   

Ser Leu Leu Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-methylpentanamido]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C20H36N4O6 (428.2635)


   

Ser Leu Pro Ile

(2S,3S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanoic acid

C20H36N4O6 (428.2635)


   

Ser Leu Pro Leu

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-methylpentanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanoic acid

C20H36N4O6 (428.2635)


   

Ser Pro Ile Ile

(2S,3S)-2-[(2S,3S)-2-{[(2S)-1-[(2S)-2-amino-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanamido]-3-methylpentanoic acid

C20H36N4O6 (428.2635)


   

Ser Pro Ile Leu

(2S)-2-[(2S,3S)-2-{[(2S)-1-[(2S)-2-amino-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanamido]-4-methylpentanoic acid

C20H36N4O6 (428.2635)


   

Ser Pro Leu Ile

(2S,3S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanamido]-3-methylpentanoic acid

C20H36N4O6 (428.2635)


   

Ser Pro Leu Leu

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanamido]-4-methylpentanoic acid

C20H36N4O6 (428.2635)


   

Thr Ile Pro Val

(2S)-2-{[(2S)-1-[(2S,3S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C20H36N4O6 (428.2635)


   

Thr Ile Val Pro

(2S)-1-[(2S)-2-[(2S,3S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-methylpentanamido]-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C20H36N4O6 (428.2635)


   

Thr Leu Pro Val

(2S)-2-{[(2S)-1-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C20H36N4O6 (428.2635)


   

Thr Leu Val Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-methylpentanamido]-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C20H36N4O6 (428.2635)


   

Thr Pro Ile Val

(2S)-2-[(2S,3S)-2-{[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanamido]-3-methylbutanoic acid

C20H36N4O6 (428.2635)


   

Thr Pro Leu Val

(2S)-2-[(2S)-2-{[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanamido]-3-methylbutanoic acid

C20H36N4O6 (428.2635)


   

Thr Pro Val Ile

(2S,3S)-2-[(2S)-2-{[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanamido]-3-methylpentanoic acid

C20H36N4O6 (428.2635)


   

Thr Pro Val Leu

(2S)-2-[(2S)-2-{[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanamido]-4-methylpentanoic acid

C20H36N4O6 (428.2635)


   

Thr Val Ile Pro

(2S)-1-[(2S,3S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-methylbutanamido]-3-methylpentanoyl]pyrrolidine-2-carboxylic acid

C20H36N4O6 (428.2635)


   

Thr Val Leu Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-methylbutanamido]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C20H36N4O6 (428.2635)


   

Thr Val Pro Ile

(2S,3S)-2-{[(2S)-1-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanoic acid

C20H36N4O6 (428.2635)


   

Thr Val Pro Leu

(2S)-2-{[(2S)-1-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanoic acid

C20H36N4O6 (428.2635)


   

Val Ile Pro Thr

(2S,3R)-2-{[(2S)-1-[(2S,3S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanoic acid

C20H36N4O6 (428.2635)


   

Val Ile Thr Pro

(2S)-1-[(2S,3R)-2-[(2S,3S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylpentanamido]-3-hydroxybutanoyl]pyrrolidine-2-carboxylic acid

C20H36N4O6 (428.2635)


   

Val Leu Pro Thr

(2S,3R)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanoic acid

C20H36N4O6 (428.2635)


   

Val Leu Thr Pro

(2S)-1-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-methylpentanamido]-3-hydroxybutanoyl]pyrrolidine-2-carboxylic acid

C20H36N4O6 (428.2635)


   

Val Pro Ile Thr

(2S,3R)-2-[(2S,3S)-2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanamido]-3-hydroxybutanoic acid

C20H36N4O6 (428.2635)


   

Val Pro Leu Thr

(2S,3R)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanamido]-3-hydroxybutanoic acid

C20H36N4O6 (428.2635)


   

Val Pro Thr Ile

(2S,3S)-2-[(2S,3R)-2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanamido]-3-methylpentanoic acid

C20H36N4O6 (428.2635)


   

Val Pro Thr Leu

(2S)-2-[(2S,3R)-2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanamido]-4-methylpentanoic acid

C20H36N4O6 (428.2635)


   

Val Thr Ile Pro

(2S)-1-[(2S,3S)-2-[(2S,3R)-2-[(2S)-2-amino-3-methylbutanamido]-3-hydroxybutanamido]-3-methylpentanoyl]pyrrolidine-2-carboxylic acid

C20H36N4O6 (428.2635)


   

Val Thr Leu Pro

(2S)-1-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-methylbutanamido]-3-hydroxybutanamido]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C20H36N4O6 (428.2635)


   

Val Thr Pro Ile

(2S,3S)-2-{[(2S)-1-[(2S,3R)-2-[(2S)-2-amino-3-methylbutanamido]-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanoic acid

C20H36N4O6 (428.2635)


   

Val Thr Pro Leu

(2S)-2-{[(2S)-1-[(2S,3R)-2-[(2S)-2-amino-3-methylbutanamido]-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanoic acid

C20H36N4O6 (428.2635)


   

PGF2alpha-G

9S,11R,15S-trihydroxy-5Z,13E-prostadienoic acid 1(3)-glyceryl ester

C23H40O7 (428.2774)


   

2-glyceryl-PGF2&alpha

9S,11R,15S-trihydroxy-5Z,13E-prostadienoic acid 2-glyceryl ester

C23H40O7 (428.2774)


   

FA 23:3;O5

9S,11R,15S-trihydroxy-5Z,13E-prostadienoic acid 2-glyceryl ester

C23H40O7 (428.2774)


   

5-(3,5-dimethyl-4-octoxyphenyl)-3-hexylthiophene-2-carbaldehyde

5-(3,5-dimethyl-4-octoxyphenyl)-3-hexylthiophene-2-carbaldehyde

C27H40O2S (428.2749)


   

Umeclidinium

Umeclidinium

C29H34NO2+ (428.2589)


C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent

   

prostaglandin F2alpha 1-glyceryl ester

prostaglandin F2alpha 1-glyceryl ester

C23H40O7 (428.2774)


A 1-monoglyceride resulting from the condensation of the carboxy group of prostaglandin F2alpha with the 1-hydroxy group of glycerol.

   

MG(PGF2alpha/0:0/0:0)

MG(PGF2alpha/0:0/0:0)

C23H40O7 (428.2774)


   

MG(0:0/PGF2alpha/0:0)

MG(0:0/PGF2alpha/0:0)

C23H40O7 (428.2774)


   

MG(PGE1/0:0/0:0)

MG(PGE1/0:0/0:0)

C23H40O7 (428.2774)


   

MG(PGD1/0:0/0:0)

MG(PGD1/0:0/0:0)

C23H40O7 (428.2774)


   

MG(0:0/PGE1/0:0)

MG(0:0/PGE1/0:0)

C23H40O7 (428.2774)


   

MG(0:0/PGD1/0:0)

MG(0:0/PGD1/0:0)

C23H40O7 (428.2774)


   

4-{[(4-Fluorophenyl)methyl]({[4-(2-methylpropoxy)phenyl]methyl}carbamoyl)amino}-1-methylpiperidin-1-ium

4-{[(4-Fluorophenyl)methyl]({[4-(2-methylpropoxy)phenyl]methyl}carbamoyl)amino}-1-methylpiperidin-1-ium

C25H35FN3O2+ (428.2713)


   

N-Acetyl-alanyl-valyl-leucyl-alanine methyl ester

N-Acetyl-alanyl-valyl-leucyl-alanine methyl ester

C20H36N4O6 (428.2635)


   

(all-E)-2,6,10,15,19,23-hexamethyltetracosa-2,4,6,8,10,12,14,16,18,20,22-undecaenedial

(all-E)-2,6,10,15,19,23-hexamethyltetracosa-2,4,6,8,10,12,14,16,18,20,22-undecaenedial

C30H36O2 (428.2715)


   

2-glyceryl-Prostaglandin F2alpha

2-glyceryl-Prostaglandin F2alpha

C23H40O7 (428.2774)


   

prostaglandin F2alpha 2-glyceryl ester

prostaglandin F2alpha 2-glyceryl ester

C23H40O7 (428.2774)


A 2-monoglyceride obtained by formal condensation of the carboxy group of prostaglandin F2alpha with the 2-hydroxy group of glycerol.

   

Glyceryl-PGF2alpha

Glyceryl-PGF2alpha

C23H40O7 (428.2774)


   
   
   

n-[1-(2-benzyl-3-methoxy-4-methyl-5-oxo-2h-pyrrol-1-yl)-3-methyl-1-oxobutan-2-yl]-2-methylhexanimidic acid

n-[1-(2-benzyl-3-methoxy-4-methyl-5-oxo-2h-pyrrol-1-yl)-3-methyl-1-oxobutan-2-yl]-2-methylhexanimidic acid

C25H36N2O4 (428.2675)


   

n-[(2r)-1-[(2s)-2-benzyl-3-methoxy-4-methyl-5-oxo-2h-pyrrol-1-yl]-3-methyl-1-oxobutan-2-yl]-2-methylhexanimidic acid

n-[(2r)-1-[(2s)-2-benzyl-3-methoxy-4-methyl-5-oxo-2h-pyrrol-1-yl]-3-methyl-1-oxobutan-2-yl]-2-methylhexanimidic acid

C25H36N2O4 (428.2675)


   

2,6,10,15,19,23-hexamethyltetracosa-2,4,6,8,10,12,14,16,18,20,22-undecaenedial

2,6,10,15,19,23-hexamethyltetracosa-2,4,6,8,10,12,14,16,18,20,22-undecaenedial

C30H36O2 (428.2715)


   

(2s)-1-[(2s,5r)-5-[(2r)-1-ethoxy-1-oxopropan-2-yl]oxolan-2-yl]butan-2-yl (2s)-2-[(2s,5r)-5-[(2r)-2-hydroxypropyl]oxolan-2-yl]propanoate

(2s)-1-[(2s,5r)-5-[(2r)-1-ethoxy-1-oxopropan-2-yl]oxolan-2-yl]butan-2-yl (2s)-2-[(2s,5r)-5-[(2r)-2-hydroxypropyl]oxolan-2-yl]propanoate

C23H40O7 (428.2774)


   

17-(3,5-dihydroxyphenyl)heptadecane-6-sulfonic acid

17-(3,5-dihydroxyphenyl)heptadecane-6-sulfonic acid

C23H40O5S (428.2596)


   

ethyl 2-{5-[2-({2-[5-(2-hydroxypropyl)oxolan-2-yl]propanoyl}oxy)butyl]oxolan-2-yl}propanoate

ethyl 2-{5-[2-({2-[5-(2-hydroxypropyl)oxolan-2-yl]propanoyl}oxy)butyl]oxolan-2-yl}propanoate

C23H40O7 (428.2774)